- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01512641
Prevalence of Dissociative Disorders in Children
Prevalence of Dissociative Disorders in Children in a Population Supported in the Medico-social and Health Structures in Provence Alpes Cote d'Azur
Schizophrenia beginning before 18 years is a clinical entity not well known because of its low incidence and difficulties in the clinical diagnosis.
However, in the investigators clinical practice, due to the specialization of the investigators service, the investigators are led to hospital to receive important feel active of patients meeting the Diagnostic and Statistical Manual of Mental Disorders IV text revision (DSM IV-TR) precose schizophrenia.
The work of us team on the theme of the relationship between Pervasive Developmental Disorders and precose Schizophrenia led us to hypothesize that a number of children in care in the medical and educational institutes, hospitals and day shelters therapeutic part-time symptoms of schizophrenia or a line real early diagnosis of schizophrenia undervalued or not diagnosed.
The main goal is to estimate the prevalence of dissociative disorders in a population of children in care institutions and medical education in child psychiatry in hospitals and others structures.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Antibes, France, 06600
- Psychiatrie infanto-juvénile - Centre Hospitalier d'Antibes
-
Fréjus, France, 83608
- Psychiatrie infanto-juvénile-Pôle femme-mère -enfant
-
Marseille, France, 13009
- Service de psychiatrie de l'enfant et de l'adolescent
-
Nice, France, 06000
- Service de psychiatrie de l'enfant et de l'adolescent
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 7 to 18 years
- Supported in the partner institutions of the study
- IQ>35 on the certificate of orientation of the Maison Départementale des Personnes Handicapées (MDPH)
- Obtaining the agreement of parents and children
Exclusion Criteria:
- QI<35 on the certificate file Guidance MDPH
- Children not speaking french
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Children with Dissociative Disorders
Children will take first the primary stage.
If one child is positive, he will pass the secondary stage.
|
Kiddie-Schedule for Affective Disorders and Schizophrenia
children who are positive to the kiddie-SADS (primary stage), will take the tests: PANSS, Scale for the Assessment of Negative Symptoms (SANS), ADI-R, scale TLC and WISC IV
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of children diagnosed with dissociative disorders
Time Frame: between 2 and 4 hours depending children
|
Rate of children diagnosed with dissociative disorders: children positive for the test Kiddie-Schedule for Affective Disorders and Schizophrenia (Kiddie-SADS).
|
between 2 and 4 hours depending children
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of children positive for test: Autism Diagnostic Interview-Revise (ADI-R).
Time Frame: 1 day on average
|
1 day on average
|
|
|
Scores of three dimensions of schizophrenia in the Positive And Negative Syndrome Scale (PANSS)
Time Frame: 4 hours
|
3 dimensions: positive symptoms, negative symptoms and general psychopathology, based on these scores the diagnostic subtype of schizophrenia is established.
|
4 hours
|
|
Score at the Test Lillois de Communication (TLC)
Time Frame: 30 minutes
|
30 minutes
|
|
|
Score on the Wechsler Intelligence Scale for Children-Fourth Edition (WISC IV)subtests and overall intelligence quotient (IQ).
Time Frame: 4 hours
|
4 hours
|
|
|
Response time to test verbal fluency, scores on the Trail Making Test A (TMT) and TMT B.
Time Frame: 30 minutes
|
30 minutes
|
Collaborators and Investigators
Investigators
- Study Director: Florence ASKENAZY, PU-PH, University Hospital of Nice
- Principal Investigator: Emmanuelle DOR, PH, University Hospital of Nice
- Principal Investigator: François POINSO, PU-PH, AP-HM
- Principal Investigator: Michèle BATTISTA, PH, Frejus's hospital
- Principal Investigator: Michel BOUBLIL, PH, Antibes's hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-API-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Bradley LegaRecruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on Primary stage
-
Lille Catholic UniversityRecruiting
-
Fox Chase Cancer CenterUniversity of South Carolina; Temple University; Thomas Jefferson University; Rutgers...RecruitingCervical Cancer | Papilloma Viral InfectionUnited States
-
Nantes University HospitalUniversité de Nantes; University of Paris 13; Institut de Recherche en Santé... and other collaboratorsCompleted
-
Second Affiliated Hospital, School of Medicine,...Completed
-
Merck Sharp & Dohme LLCRecruitingPneumococcal InfectionUnited States
-
Odense University HospitalRegion of Southern Denmark; Odense Patient Data Explorative NetworkActive, not recruitingPeriprosthetic Knee InfectionDenmark
-
University of Nevada, RenoNational Institute of Mental Health (NIMH); The Catholic University of AmericaCompleted
-
Sichuan Provincial People's HospitalNot yet recruitingMicrotia | Treatment Outcome | Outcome Assessment | Reconstruction | Surgery Related Complications Rate | RCTChina
-
Radboud University Medical CenterCochlear Bone Anchored SolutionsTerminatedHearing Impaired Children | Hearing Impairment, ConductiveNetherlands
-
Radboud University Medical CenterOticon MedicalCompletedHearing Impaired Children | Hearing Impairment, ConductiveNetherlands